genetic familial mutations
492 articles
Let’s Win and Partners Present Poster and Abstract at Gastrointestinal Cancer Symposium
Let’s Win and partners presented a poster and abstract that highlights the first pancreatic cancer group Twitter chat at the January 2018 ASCO GI meeting.
Pancreatic Cancer Exceptional Responders and the Immune System Link
Dr. Vinod Balachandran looks at the immune system of exceptional responders–patients who respond extremely well to chemotherapy–for treatment clues.
PATHFINDER Blood Test Trial Focused on Early Detection
Dr. Minetta Liu is part of the team conducting a clinical trial to find biomarkers that will become an easy blood test for pancreatic cancer.
Diversity Lacking in Pancreatic Cancer Trials
Drs. Kelly Herremans and Jose Trevino report on the lack of diversity in pancreatic cancer clinical trials, and possible root causes.
Comparing a Standard Chemotherapy With and Without a PARP Inhibitor
A clinical trial compares standard chemotherapy with and without the addition of a PARP inihibitor, for patients whose pancreatic cancer is spreading again.
Research and Other Highlights from the 2023 AACR Annual Meeting
The 2023 AACR meeting focused on the latest research into KRAS, other immunotherapy approaches, and honored Dr. Elizabeth Jaffee.
Shedding Light on Chemo Brain
What is chemo fog or chemo brain? Are there techniques to counteract the side effects of chemotherapy on the brain?
What You Should Know About Tumor Boards
A tumor board brings together experts in different treatment fields to discuss your case and help direct your pancreatic cancer treatment.
Unraveling the Web for Reliable Pancreatic Cancer Information
Dr. Mark Lewis and journalist Steve Doig explain how to judge whether the information about pancreatic cancer on the internet is from a reliable source.
At the Table: Advocating For Yourself
Patients and survivors discuss the value of advocating for yourself during treatment, whether choosing a doctor or participating in a trial.
The Cancer Moonshot
Dr. Elizabeth Jaffee of Johns Hopkins is part of the Cancer Moonshot’s Blue Ribbon Panel, and she explains the goals of the program.